Spectrum Pharmaceuticals, Inc. (SPPI) to Present Corporate Update at the Goldman, Sachs & Co. 34th Annual Global Healthcare Conference in Rancho Palos Verdes on June 11th
6/6/2013 6:54:02 AM
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) Announces Positive Data from the BELIEF Trial Presented at the 2013 American Society of Clinical Oncology Annual Meeting
6/3/2013 7:18:31 AM
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) Highlights Six Abstracts of Clinical Data at the 2013 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois, May 31 – June 4, 2013
5/31/2013 7:12:03 AM
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) to Present Corporate Update at the Jefferies and Co. 2013 Global Healthcare Conference in New York City on June 5th
5/29/2013 7:37:14 AM
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) to Present Corporate Update at the Deutsche Bank (DB) 38th Annual Health Care Conference in Boston on May 30th
5/23/2013 7:49:04 AM
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) to Present Corporate Update at the UBS Global Healthcare Conference in New York City on May 20th
5/13/2013 7:15:18 AM
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) to Present Corporate Update at the Bank of America (BAC) Merrill Lynch 2013 Health Care Conference in Las Vegas on May 14th
5/10/2013 8:02:15 AM
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) Reports Financial Results for First Quarter 2013
5/9/2013 7:45:38 AM
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) Announces First Quarter 2013 Financial Results Teleconference and Webcast
5/2/2013 8:16:22 AM
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) Initiates Phase 2 Study of Long-Acting GCSF Drug Candidate, SPI-2012, for the Treatment of Chemotherapy-Induced Neutropenia
4/8/2013 10:02:07 AM
More...
|
|